NeoGenomics, Inc. (NEO)
17.25
+0.37
(+2.19%)
USD |
NASDAQ |
Oct 15, 16:00
17.25
0.00 (0.00%)
Pre-Market: 20:00
NeoGenomics Research and Development Expense (Quarterly) : 10.76M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.76M |
| March 31, 2026 | 9.534M |
| December 31, 2025 | 9.179M |
| September 30, 2025 | 8.694M |
| June 30, 2025 | 9.023M |
| March 31, 2025 | 10.18M |
| December 31, 2024 | 7.969M |
| September 30, 2024 | 7.684M |
| June 30, 2024 | 7.886M |
| March 31, 2024 | 7.62M |
| December 31, 2023 | 7.127M |
| September 30, 2023 | 5.285M |
| June 30, 2023 | 7.502M |
| March 31, 2023 | 7.395M |
| December 31, 2022 | 6.675M |
| September 30, 2022 | 7.312M |
| June 30, 2022 | 8.626M |
| March 31, 2022 | 7.713M |
| December 31, 2021 | 8.513M |
| September 30, 2021 | 7.409M |
| June 30, 2021 | 3.495M |
| March 31, 2021 | 2.456M |
| December 31, 2020 | 2.10M |
| September 30, 2020 | 1.964M |
| June 30, 2020 | 2.105M |
| Date | Value |
|---|---|
| March 31, 2020 | 2.06M |
| December 31, 2019 | 2.08M |
| September 30, 2019 | 2.611M |
| June 30, 2019 | 2.587M |
| March 31, 2019 | 1.209M |
| December 31, 2018 | 0.526M |
| September 30, 2018 | 0.446M |
| June 30, 2018 | 1.073M |
| March 31, 2018 | 0.956M |
| December 31, 2017 | 0.556M |
| September 30, 2017 | 1.27M |
| June 30, 2017 | 0.947M |
| March 31, 2017 | 0.862M |
| December 31, 2016 | 0.93M |
| September 30, 2016 | 0.967M |
| June 30, 2016 | 1.251M |
| March 31, 2016 | 1.32M |
| December 31, 2015 | 1.80M |
| September 30, 2015 | 0.815M |
| June 30, 2015 | 0.743M |
| March 31, 2015 | 0.613M |
| December 31, 2014 | 0.319M |
| September 30, 2014 | 0.925M |
| June 30, 2014 | 0.578M |
| March 31, 2014 | 0.572M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median